376 related articles for article (PubMed ID: 36625571)
1. Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans
Lei J; Huang J; Xin C; Liu F; Zhang J; Xie Y; Mao Y; Chen W; Song Z
Microbiol Spectr; 2023 Feb; 11(1):e0380122. PubMed ID: 36625571
[TBL] [Abstract][Full Text] [Related]
2. Holotoxin A
Liao M; Xia X; Meng Q; Zhu C; Liao B; Wang J; Gou L; Zhou X; Yuan W; Cheng L; Ren B
Br J Pharmacol; 2024 Jun; 181(12):1857-1873. PubMed ID: 38382564
[TBL] [Abstract][Full Text] [Related]
3. Perspective on receptor-associated immune response to Candida albicans single and mixed infections: Implications for therapeutics in oropharyngeal candidiasis.
Yang L; Cheng T; Shao J
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37533203
[TBL] [Abstract][Full Text] [Related]
4. Cinnamaldehyde inhibits Candida albicans growth by causing apoptosis and its treatment on vulvovaginal candidiasis and oropharyngeal candidiasis.
Chen L; Wang Z; Liu L; Qu S; Mao Y; Peng X; Li YX; Tian J
Appl Microbiol Biotechnol; 2019 Nov; 103(21-22):9037-9055. PubMed ID: 31659418
[TBL] [Abstract][Full Text] [Related]
5. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
6. Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in
Chen M; Cheng T; Xu C; Pan M; Wu J; Wang T; Wu D; Yan G; Wang C; Shao J
Virulence; 2022 Dec; 13(1):428-443. PubMed ID: 35195502
[No Abstract] [Full Text] [Related]
7. VT-1161 protects mice against oropharyngeal candidiasis caused by fluconazole-susceptible and -resistant Candida albicans.
Break TJ; Desai JV; Natarajan M; Ferre EMN; Henderson C; Zelazny AM; Siebenlist U; Hoekstra WJ; Schotzinger RJ; Garvey EP; Lionakis MS
J Antimicrob Chemother; 2018 Jan; 73(1):151-155. PubMed ID: 29040636
[TBL] [Abstract][Full Text] [Related]
8. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
[TBL] [Abstract][Full Text] [Related]
9. Molecular Elucidation of Riboflavin Production and Regulation in Candida albicans, toward a Novel Antifungal Drug Target.
Demuyser L; Palmans I; Vandecruys P; Van Dijck P
mSphere; 2020 Aug; 5(4):. PubMed ID: 32759338
[No Abstract] [Full Text] [Related]
10. Perillaldehyde: A promising antifungal agent to treat oropharyngeal candidiasis.
Chen L; Qu S; Yang K; Liu M; Li YX; Keller NP; Zeng X; Tian J
Biochem Pharmacol; 2020 Oct; 180():114201. PubMed ID: 32822688
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
[TBL] [Abstract][Full Text] [Related]
12. Iron Chelator Deferasirox Reduces
Puri S; Kumar R; Rojas IG; Salvatori O; Edgerton M
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718249
[No Abstract] [Full Text] [Related]
13. Distribution and antifungal susceptibility profiles of Candida species isolated from people living with HIV/AIDS in a public hospital in Goiânia, GO, Brazil.
Freitas VAQ; Santos AS; Zara ALSA; Costa CR; Godoy CSM; Soares RBA; Ataídes FS; Silva MDRR
Braz J Microbiol; 2023 Mar; 54(1):125-133. PubMed ID: 36371517
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Biofilm Efficacy of Caffeic Acid Phenethyl Ester (CAPE)
de Barros PP; Rossoni RD; Garcia MT; Kaminski VL; Loures FV; Fuchs BB; Mylonakis E; Junqueira JC
Front Cell Infect Microbiol; 2021; 11():700305. PubMed ID: 34408988
[No Abstract] [Full Text] [Related]
15. Candida albicans
Naseem S; Douglas LM; Konopka JB
mBio; 2019 Nov; 10(6):. PubMed ID: 31719181
[TBL] [Abstract][Full Text] [Related]
16. Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis.
He J; Thomas MA; de Anda J; Lee MW; Van Why E; Simpson P; Wong GCL; Grayson MH; Volkman BF; Huppler AR
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423961
[No Abstract] [Full Text] [Related]
17. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis.
Zhu C; Liao B; Ye X; Zhou Y; Chen X; Liao M; Cheng L; Zhou X; Ren B
Int J Antimicrob Agents; 2021 Sep; 58(3):106394. PubMed ID: 34197906
[TBL] [Abstract][Full Text] [Related]
18. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Martinez M; López-Ribot JL; Kirkpatrick WR; Coco BJ; Bachmann SP; Patterson TF
J Clin Microbiol; 2002 Sep; 40(9):3135-9. PubMed ID: 12202543
[TBL] [Abstract][Full Text] [Related]
19. Antifungal efficacy of atorvastatin-containing emulgel in the treatment of oral and vulvovaginal candidiasis.
de Oliveira Neto AS; Souza ILA; Amorim MES; de Freitas Souza T; Rocha VN; do Couto RO; Fabri RL; de Freitas Araújo MG
Med Mycol; 2021 May; 59(5):476-485. PubMed ID: 32823281
[TBL] [Abstract][Full Text] [Related]
20. Antifungal activity of vitamin D
Lei J; Xiao W; Zhang J; Liu F; Xin C; Zhou B; Chen W; Song Z
Microbiol Res; 2022 Dec; 265():127200. PubMed ID: 36162148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
